Norway · How much has Zelluna Immunotherapy raised?
Zelluna Immunotherapy has raised $6.1M across 1 round since 2026.
Norway · Funded startup
Who invested in Zelluna Immunotherapy
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 5 months ago
Follow Zelluna Immunotherapy and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$6.1Mraised across 1 round since 2026, from 1 source
- Latest round
- Round, $6.1MJun 2026
- Investors
- 0
The rounds
- Jun 2026Round$6.1M
No investor was named in the report.
Source recorded
Founders and team
From Zelluna Immunotherapy's own website: 1 founder, 10 on the team.
Anders TuvChair of the Board of Directors, co-founder
- Namir HassanChief Executive Officer
- Anders HolmChief Operating Officer and Head of Business Development
- Emilie GauthyChief Technology Officer
- Geir Christian MelenChief Financial Officer
- Luise WeigandChief Scientific Officer
- Julia InoHead of Project Management and Clinical Project Manager
- Bent JakobsenBoard member
- Charlotte Sofie Bergsagel Berg-SvendsenBoard member
- Eva-Lotta AllanBoard member
- Martin WelschofBoard member
Quick answers about Zelluna Immunotherapy
When did Zelluna Immunotherapy last raise?
Zelluna Immunotherapy's most recent round was an Undisclosed round of $6.1M in Jun 2026.
What was Zelluna Immunotherapy's biggest round?
Its most recent round, $6.1M in Jun 2026, is also its largest on record.
What stage is Zelluna Immunotherapy at?
Zelluna Immunotherapy's latest named round is an Undisclosed round, in Jun 2026.
Where is Zelluna Immunotherapy based?
Zelluna Immunotherapy is based in Norway.
Companies like Zelluna Immunotherapy
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.